P0J Stock Chart & Stats
€0.02
€0.00(0.00%)
At close: 4:00 PM EDT
€0.02
€0.00(0.00%)
Day’s Range― - ―
52-Week Range<€0.01 - €0.03
Previous CloseN/A
Volume7.50K
Average Volume (3M)4.33K
Market Cap
€13.04M
Enterprise Value€13.09M
Total Cash (Recent Filing)€4.36M
Total Debt (Recent Filing)€170.00K
Price to Earnings (P/E)―
Beta-3.65
Next Earnings
Apr 01, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding3,468,080,600
10 Day Avg. Volume4,328
30 Day Avg. Volume4,328
Financial Highlights & Ratios
PEG Ratio0.14
Price to Book (P/B)2.48
Price to Sales (P/S)9.21
P/FCF Ratio-6.19
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue ReboundThe return to revenue growth after weakness through 2024 indicates some stabilization in customer demand and commercial activity. If maintained, a larger revenue base could improve operating leverage, support investment in aptamer development, and help the company progress toward sustainable scale.
Improving Gross MarginMeaningful gross-margin expansion suggests improving unit economics and a better contribution from each sale. Sustaining this improvement would provide a stronger foundation for absorbing operating costs, reducing losses as revenue grows, and supporting the commercial viability of the aptamer platform.
Low Financial LeverageThe stronger equity base and very low leverage provide a more resilient financial structure than in prior years. Limited debt exposure reduces interest and refinancing pressure, preserving greater flexibility to fund operations and pursue development while the business works toward profitability.
Bears Say
Persistent Deep LossesProfitability remains the central fundamental weakness because operating costs are still far above the revenue base. Continued deep losses limit internally generated funding, weaken returns on capital, and make progress toward a self-sustaining business dependent on substantial improvement in scale or cost control.
Ongoing Cash BurnPersistent negative operating and free cash flow means the company is not yet funding its activities from recurring operations. Even with some moderation in the burn rate, continued cash consumption can increase reliance on external funding and constrain investment in growth or product development.
Revenue VolatilityThe history of sharp revenue contraction followed by a later rebound indicates an unstable commercial trajectory rather than a consistently compounding revenue engine. Such volatility makes planning harder, delays operating leverage, and increases the risk that margin improvements will not translate into durable profitability.
Aptamer Group Plc News
P0J FAQ
What was Aptamer Group Plc’s price range in the past 12 months?
Aptamer Group Plc lowest stock price was <€0.01 and its highest was €0.03 in the past 12 months.
What is Aptamer Group Plc’s market cap?
Aptamer Group Plc’s market cap is €13.04M.
When is Aptamer Group Plc’s upcoming earnings report date?
Aptamer Group Plc’s upcoming earnings report date is Apr 01, 2027 which is in 159 days.
How were Aptamer Group Plc’s earnings last quarter?
Aptamer Group Plc released its earnings results on Oct 13, 2026. The company reported €0 earnings per share for the quarter.
Is Aptamer Group Plc overvalued?
According to Wall Street analysts Aptamer Group Plc’s price is currently Overvalued.
Does Aptamer Group Plc pay dividends?
Aptamer Group Plc does not currently pay dividends.
What is Aptamer Group Plc’s EPS estimate?
Aptamer Group Plc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Aptamer Group Plc have?
Aptamer Group Plc has 3,468,080,600 shares outstanding.
What happened to Aptamer Group Plc’s price movement after its last earnings report?
Aptamer Group Plc reported an EPS of €0 in its last earnings report. Following the earnings report the stock price went down -13.043%.
Which hedge fund is a major shareholder of Aptamer Group Plc?
Currently, no hedge funds are holding shares in DE:P0J
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Aptamer Group Plc
Aptamer Group plc, an international company headquartered in York, United Kingdom, specializes in providing advanced binders for applications spanning research, diagnostics, and therapeutics. Their innovative binder technology is engineered to resolve challenges often associated with traditional molecular tools, such as antibodies, offering crucial solutions to bioprocessing, diagnostic, and pharmaceutical scientists. Established in 2014, the company primarily serves pharmaceutical corporations, diagnostic development firms, and various research institutes.
Technical Analysis
Avacta Group plc
―
Bioventix
―
Oxford BioDynamics
―
Fusion Antibodies Plc
―
Arecor Therapeutics PLC
―